COPD trials in United Kingdom
51 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleChronic Respiratory Disease Participant Engagement Study
- Where
- London
- Age
- 18 years and over
- People
- 500
- Run by
- Richmond Research Institute
See details and how to joinNCT07924462 - Phase 2Taking peopleA Study of Brenipatide (LY3537031) in Adult Participants With Moderate-to-Severe Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Cheadle, Ely, Hounslow, London, Penzance, West Kirby
- Age
- 40 years to 75 years
- People
- 606 worldwide
- Run by
- Eli Lilly and Company
See details and how to joinNCT07759245 · EU 2026-525480-41-00 - Phase 2Taking peoplePhase 2b Efficacy and Safety Study of AERO-007, an Inhaled LABA+LAMA Combination for Nebulization Delivery in COPD Patients
- Where
- London, Manchester
- Age
- 40 years to 75 years
- People
- 64
- Run by
- AeroRx Therapeutics Inc.
See details and how to joinNCT07896252 - No phaseTaking peopleComparing Advanced Technologies to Standard Testing for the Diagnosis of Airway Disease in Hospital and Community Settings
- Where
- Andover, Southampton
- Age
- 18 years and over
- People
- 300
- Run by
- University Hospital Southampton NHS Foundation Trust
See details and how to joinNCT07798596 - Phase 2Taking peopleA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Where
- Bradford, Cottingham, Glasgow, Harrow, London, Newcastle upon Tyne, Thetford, Wythenshawe
- Age
- 40 years and over
- People
- 987 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07082738 - Phase 3Taking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- Where
- Chertsey, London, Milton Keynes, Reading, Rotherham, Salford, Southampton
- Age
- 40 years to 80 years
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190222 · EU 2024-518213-25-00 - No phaseTaking peoplePASS to Assess Cardiovascular and Cerebrovascular Events in COPD Patients Initiating Fixed Triple Therapy (DPI or pMDI)
- Where
- London
- Age
- 40 years and over
- People
- 25,000
- Run by
- Chiesi Farmaceutici S.p.A.
See details and how to joinNCT05652439 - Phase 2/3Taking peopleA Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Where
- Bradford, Chertsey, Glasgow, Leicester, London, Manchester, North Shields
- Age
- 35 years to 80 years
- People
- 1,156 worldwide
- Run by
- Pfizer
See details and how to joinNCT07363694 · EU 2024-518587-12-00 - Phase 2Taking peopleTrial Comparing the Safety and Efficacy of Two Different Oral VPV Doses With Placebo as Treatment for RV in Participants With COPD
- Where
- Bromborough, Glasgow, London, Milton Keynes, Wolverhampton
- Age
- 40 years to 85 years
- People
- 180 worldwide
- Run by
- Altesa Biosciences, Inc.
See details and how to joinNCT07610395 - Phase 3Enrolling by invitationA Study to Evaluate the Long-term Safety and Efficacy of Lunsekimig in Adult Participants With Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Chertsey, Rotherham
- Age
- 40 years to 80 years
- People
- 1,508 worldwide
- Run by
- Sanofi
See details and how to joinNCT07793409 - Phase 4Taking peopleA Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- Where
- Bradford, Dundee, Leicester, Newcastle upon Tyne, Sheffield, Southampton
- Age
- 40 years to 85 years
- People
- 218 worldwide
- Run by
- Sanofi
See details and how to joinNCT07053423 - Phase 1/2Taking peopleA Study of RO7830698 in Healthy Participants and Participants With Chronic Obstructive Pulmonary Disease
- Where
- Wythenshawe
- Age
- 18 years to 80 years
- People
- 104
- Run by
- Hoffmann-La Roche
See details and how to joinNCT07822334 - No phaseTaking peopleBronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3
- Where
- London
- Age
- 40 years to 84 years
- People
- 250 worldwide
- Run by
- Apreo Health, Inc.
See details and how to joinNCT06891755 - Phase 3Taking peopleEfficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Where
- Bradford, Bristol, Harrow, Leicester, London, Oxford, Worthing
- Age
- 40 years to 80 years
- People
- 942 worldwide
- Run by
- Sanofi
See details and how to joinNCT07190209 · EU 2024-518016-39-00 - No phaseTaking peopleA Study to Understand the Accuracy of a New Breathing Device Compared to Standard Testing for Asthma and COPD
- Where
- Liverpool
- Age
- 18 years to 110 years
- People
- 1,200
- Run by
- Liverpool Heart and Chest Hospital NHS Foundation Trust
See details and how to joinNCT07253883 - No phaseTaking peopleStudy of Hospitalised Patients With Acute Respiratory Conditions
- Where
- Leicester
- Age
- 18 years to 90 years
- People
- 500
- Run by
- University of Leicester
See details and how to joinNCT05095090 - Phase 3Taking peopleDepemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- Where
- Bedford, Corby, Dagenham, Edinburgh, Glasgow, Llanelli, London, Manchester, Oxford, Portsmouth, Salford, Uxbridge
- Age
- 40 years to 80 years
- People
- 961 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06961214 · EU 2024-520417-41-00 - No phaseNot yet taking people in United KingdomEffectiveness of Pollution Monitoring in Clinical Exercise Rehabilitation
- Where
- Leicester
- Age
- 18 years and over
- People
- 80
- Run by
- University of Leicester
See details and how to joinNCT07500948 - Phase 3Taking peopleA Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Where
- Bicester, Bollington, Bradford, Cardiff, Chesterfield, Corby, Cottingham, Fowey, Glasgow, Hounslow, Liverpool, London, Manchester, Newquay, Northallerton, North Somerset, Norwich, Nottingham, Perth, Poole, Sheffield, Torbay, Whitney, Witney
- Age
- 40 years to 80 years
- People
- 5,250 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06283966 · EU 2023-507407-59-00 - Phase 4Taking peopleA Study to Investigate the Effect of Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI) Compared With Placebo MDI on Heart and Lung Function in Participants With Chronic Obstructive Pulmonary Disease (COPD) and Hyperinflation
- Where
- Harefield, London, Manchester
- Age
- 40 years to 80 years
- People
- 56 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07073950 · EU 2025-521987-37-00 - No phaseTaking peopleAn Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
- Where
- London
- Age
- 40 years to 80 years
- People
- 200 worldwide
- Run by
- Pulmonx Corporation
See details and how to joinNCT06035120 - No phaseEnrolling by invitationThe Feasibility of Electrical Impedance Tomography to Guide Non-invasive Respiratory Interventions in Chronic Respiratory Disease
- Where
- London
- Age
- 18 years and over
- People
- 20
- Run by
- Royal Free Hospital NHS Foundation Trust
See details and how to joinNCT07810283 - Phase 3Taking peopleA Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Where
- Bradford, Brighton, Cottingham, Glasgow, Halifax, Leeds, Portsmouth, Tyne and Wear, Wakefield
- Age
- 40 years to 80 years
- People
- 990 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06883305 · EU 2024-517458-90-00 - Phase 1Taking peopleTo Identify if a COPD Self-management App Can Safety and Appropriately Identify When Patients Are Not on the Best Medication Plan for Their COPD Symptoms and Support Their COPD Management.
- Where
- Southampton
- Age
- 18 years and over
- People
- 746
- Run by
- University of Southampton
See details and how to joinNCT07797985 - No phaseTaking peopleBalance Training Following Pulmonary Rehabilitation on Balance in People With Chronic Obstructive Pulmonary Disease (COPD)
- Where
- Middlesbrough, Northallerton, Stockton-on-Tees
- People
- 77
- Run by
- Samantha Harrison
See details and how to joinNCT07750821